127
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

The effects of minocycline on proliferation, differentiation and migration of neural stem/progenitor cells

, , , &
Pages 601-609 | Received 28 Jul 2019, Accepted 21 Nov 2019, Published online: 05 Dec 2019
 

Abstract

Purpose: There are several attempts to enhance the capacities of neural stem/progenitor cells (NS/PCs) as a probable source of stem cell therapy for neurodegerative diseases. The evidence shows that minocycline has several non-antibacterial effects in neurodegenerative diseases. We aimed to investigate the effect of minocycline on proliferation, differentiation and migration of embryonic NS/PCs.

Materials and methods: NS/PCs extracted from ganglionic eminence of 13.5-day embryonic mice were cultured according to neurosphere protocol. After second passage they were exposed to different doses of minocycline for 7 days. The number and diameter of neurospheres were assessed to evaluate their proliferation. Migration was estimated based on the distances traveled by the cells. Because of the importance of NS/PCs behaviors in 3-dimentional environment, all assessments were done in 3-dimentional and 2-dimentional cultures. Moreover, the fate of NS/PCs to neuron or glial cells was studied.

Results: NS/PCs exposed to 1 μg/ml and 10 μg/ml of minocycline and those in untreated group traveled significantly longer distances compared to those treated with 50 μg/ml and 100 μg/ml of minocycline. In addition, higher doses of minocycline reduced the NS/PCs proliferation remarkably compared to control condition just in 2-D culture. However, the differentiation capacity of cells was not significantly affected by 1 and 10 μg/ml of minocycline.

Conclusion: The behavior of NS/PCs depends on minocycline dose as well as the characteristics of environment.

Disclosure statement

The authors declare that there is no conflict of interest regarding the publication of this article

Additional information

Funding

The present study was supported by Shiraz University of Medical Sciences (Grant no. 95-01-74-13667).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.